Education
About Us
Working with TipRanks
Follow Us
Polarityte, Inc. (RGTPQ)
OTHER OTC:RGTPQ
RGTPQ Stock Chart & Stats
Day’s Range― - ―
52-Week Range<$0.01 - $0.22
Previous CloseN/A
Volume54.00
Average Volume (3M)N/A
Market Cap
$1.15M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta7.15
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding26,962,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.09
Price to Sales (P/S)15.17
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
RGTPQ FAQ
What was Polarityte, Inc.’s price range in the past 12 months?
Polarityte, Inc. lowest stock price was <$0.01 and its highest was $0.22 in the past 12 months.
What is Polarityte, Inc.’s market cap?
Polarityte, Inc.’s market cap is $1.15M.
When is Polarityte, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Polarityte, Inc.’s earnings last quarter?
Currently, no data Available
Is Polarityte, Inc. overvalued?
According to Wall Street analysts Polarityte, Inc.’s price is currently Overvalued.
Does Polarityte, Inc. pay dividends?
Polarityte, Inc. does not currently pay dividends.
What is Polarityte, Inc.’s EPS estimate?
Polarityte, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Polarityte, Inc. have?
Polarityte, Inc. has 26,962,000 shares outstanding.
What happened to Polarityte, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Polarityte, Inc.?
Currently, no hedge funds are holding shares in RGTPQ
Company Description
Polarityte, Inc.
RegenETP, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; and other tissue regeneration products. The company was formerly known as PolarityTE, Inc. and changed its name to RegenETP, Inc. in August 2023. RegenETP, Inc. is headquartered in Salt Lake City, Utah.
PolarityTE (RGTPQ) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Ownership Overview
―
Insiders
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---